John W Kusek Selected Research

Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

1/2016	Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial.
6/2014	Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
12/2013	Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
7/2013	Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia.
9/2011	Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial.
9/2011	Effects of 100 and 300 units of onabotulinum toxin A on lower urinary tract symptoms of benign prostatic hyperplasia: a phase II randomized clinical trial.
5/2011	Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.
4/2011	Long-term treatment with finasteride improves clinical progression of benign prostatic hyperplasia in men with an enlarged versus a smaller prostate: data from the MTOPS trial.
6/2009	Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial.
9/2008	Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John W Kusek Research Topics

Disease

56	Chronic Renal Insufficiency 04/2024 - 12/2002
26	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2002
21	Chronic Kidney Failure (Chronic Renal Failure) 05/2019 - 07/2003
19	Kidney Diseases (Kidney Disease) 12/2021 - 11/2002
18	Renal Insufficiency (Renal Failure) 01/2022 - 07/2003
15	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2016 - 01/2002
13	Fistula 12/2021 - 01/2005
12	Arteriovenous Fistula 12/2021 - 01/2005
10	Urinary Incontinence 01/2017 - 12/2003
10	Lower Urinary Tract Symptoms 01/2016 - 01/2006
9	Inflammation (Inflammations) 01/2019 - 07/2006
9	Pelvic Pain 01/2018 - 08/2002
9	Proteinuria 04/2016 - 03/2002
8	Albuminuria 01/2019 - 03/2002
8	Hypertension (High Blood Pressure) 01/2019 - 03/2002
7	Prostatitis 09/2011 - 08/2002
6	Stress Urinary Incontinence 09/2016 - 05/2007
5	Diabetes Mellitus 01/2019 - 08/2011
5	Insulin Resistance 01/2019 - 09/2006
5	Pain (Aches) 01/2018 - 07/2004
5	Heart Failure 05/2017 - 04/2015
5	Myocardial Infarction 05/2017 - 04/2011
4	Thrombosis (Thrombus) 01/2018 - 01/2005
4	Anemia 11/2017 - 02/2014
4	Interstitial Cystitis (Interstitial Cystitis, Chronic) 10/2015 - 10/2007
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2015 - 03/2009
4	Urinary Tract Infections (Urinary Tract Infection) 12/2012 - 12/2003
3	Urge Urinary Incontinence (Urge Incontinence) 11/2012 - 08/2008
3	Disease Progression 04/2011 - 12/2003
3	Malnutrition (Nutritional Deficiencies) 12/2010 - 07/2003
3	Infections 08/2008 - 12/2002
3	Urinary Retention 01/2006 - 04/2003
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 09/2012
2	Hyperplasia 05/2019 - 10/2017
2	Atrial Fibrillation 01/2019 - 01/2016
2	Urinary Calculi (Urinary Calculus) 01/2018 - 01/2017
2	Pathologic Constriction (Stenosis) 10/2017 - 05/2009
2	Ischemic Stroke 05/2017 - 01/2017
2	Peripheral Arterial Disease 05/2017 - 01/2017
2	Urolithiasis 01/2017 - 03/2013
2	Stroke (Strokes) 05/2016 - 08/2015
2	Hypertrophy 01/2016 - 11/2011

Drug/Important Bio-Agent (IBA)

21	CreatinineIBA 01/2019 - 03/2002
11	C-Reactive ProteinIBA 01/2019 - 12/2002
10	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2007
9	Finasteride (Propecia)FDA LinkGeneric 01/2016 - 04/2003
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2006
8	Serum AlbuminIBA 01/2019 - 12/2002
7	MineralsIBA 05/2019 - 09/2005
7	Cystatin CIBA 05/2017 - 07/2007
7	Doxazosin (Cardura)FDA LinkGeneric 01/2016 - 12/2003
7	HomocysteineIBA 04/2011 - 11/2002
6	Fibroblast Growth Factor-23IBA 05/2019 - 06/2011
6	AlbuminsIBA 01/2018 - 07/2003
6	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 03/2002
6	Interleukin-6 (Interleukin 6)IBA 05/2017 - 12/2012
5	Retinaldehyde (Retinal)IBA 01/2021 - 09/2012
5	Hemoglobins (Hemoglobin)IBA 01/2019 - 08/2015
5	Fibrinogen (Factor I)FDA Link 01/2019 - 01/2004
5	Dietary ProteinsIBA 11/2010 - 04/2005
4	Antidepressive Agents (Antidepressants)IBA 04/2024 - 08/2007
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019 - 12/2012
4	HDL CholesterolIBA 01/2019 - 09/2006
4	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2005
4	Folic Acid (Vitamin M)FDA LinkGeneric 08/2016 - 11/2002
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2011 - 07/2003
3	CollagenIBA 05/2019 - 03/2014
3	InterleukinsIBA 01/2019 - 03/2014
3	CholesterolIBA 01/2019 - 09/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2015
3	Tamsulosin (Flomax)FDA LinkGeneric 01/2018 - 10/2004
3	Phosphorus (Red Phosphorus)IBA 09/2017 - 09/2005
3	SodiumIBA 05/2016 - 02/2014
3	CalciumIBA 04/2016 - 09/2005
3	Phosphates (Orthophosphate)IBA 10/2015 - 06/2011
3	Ramipril (Altace)FDA LinkGeneric 01/2013 - 07/2003
3	LipidsIBA 07/2012 - 01/2005
3	Glucose (Dextrose)FDA LinkGeneric 03/2009 - 06/2006
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2008 - 08/2004
2	Vitamin D FDA LinkGeneric 05/2019 - 06/2017
2	Parathyroid Hormone (Parathormone)IBA 05/2019 - 04/2016
2	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 04/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 04/2015
2	Troponin T (Troponin T1)IBA 01/2019 - 04/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 01/2015
2	Hormones (Hormone)IBA 01/2017 - 06/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2016 - 05/2009
2	Alkaline PhosphataseIBA 04/2016 - 01/2012
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2016 - 01/2014
2	Bicarbonates (Hydrogen Carbonate)IBA 01/2016 - 11/2010

Therapy/Procedure

35	Therapeutics 01/2018 - 01/2002
23	Renal Dialysis (Hemodialysis) 12/2021 - 07/2004
6	Transplantation 08/2016 - 12/2006
5	Suburethral Slings (Tension-Free Vaginal Tape) 09/2016 - 11/2012
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 06/2007
3	Glycemic Control 05/2017 - 04/2009
3	Drug Therapy (Chemotherapy) 12/2013 - 01/2002
3	Massage (Zone Therapy) 01/2013 - 07/2006
3	Protein-Restricted Diet (Diet, Protein Restricted) 02/2009 - 04/2005
2	Peritoneal Dialysis 01/2018 - 03/2013